Skip to content

Respirator N95 masks to prevent the inhalation of urban air pollutants

Respirator N95 masks to prevent the inhalation of urban air pollutants: a pilot intervention study in Hanoi, Vietnam

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74390617
Enrollment
40
Registered
2009-08-04
Start date
2009-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Air pollution & respiratory problems Not Applicable Respiratory disorder, unspecified

Interventions

The intervention consists of wearing a R95 particulate respirator (3M, 9900 series) on assigned days for a 2-week period. All volunteers start at the same time and will be randomly allocated to a spec

Sponsors

University of Oxford (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy male and female Vietnamese volunteers over 18 years of age

Exclusion criteria

Exclusion criteria: 1. Smoking tobacco 2. Cooking at home with biomass fuel 3. Not willing to stop eating grilled food during study period of 2 weeks 4. Home address is at a main city road 5. Not willing to wear a face mask 6. Type of work prohibits wearing a mask (e.g. regular conversation) 7. No direct access to mobile phone 8. Not able to read or write 9. Not able to complete the study for other reasons 10. Respirator mask does not fit (determined by fitness test) 11. No informed consent

Design outcomes

Primary

MeasureTime frame
Concentration of exhaust and smoking metabolites in urine, with 1-hydroxypyrene as the primary endpoint metabolite. Outcomes will be measured at day 0 (baseline), day 4, day 7, day 11 and day 14.

Secondary

MeasureTime frame
Other metabolites in the urine including 1-hydroxynaphthalene, 2-hydroxynaphthalene, 2-hydroxyfluorene, 3-hydroxyfluorene, 9-hydroxyfluorene, 1-hydroxyphenanthrene, 2-hydroxyphenanthrene, 3-hydroxyphenanthrene, 4-hydroxyphenanthrene, Cotinine and Creatinine. Outcomes will be measured at day 0 (baseline), day 4, day 7, day 11 and day 14.

Countries

Viet Nam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026